Home » Topics » Regulatory » Patents

Patents
RSS

Investigators from SIMM and GIBH present EGFR inhibitors

June 10, 2016

reMYND develops agents for amyloid-related diseases

June 10, 2016

Sichuan Haisco Pharmaceutical discloses anticancer agents

June 10, 2016

Shionogi patents P2X3 and/or P2X2/3 receptor antagonists

June 10, 2016

Kalvista Pharmaceuticals describes KLKB1 inhibitors

June 10, 2016

Bayer Schering Pharma describes IRAK-4 inhibitors

June 9, 2016

Korea Institute of Science and Technology reports development of protein kinase inhibitors

June 9, 2016

Merck Patent presents IRAK inhibitors

June 9, 2016

Mochida Pharmaceutical discloses OX2 receptor antagonists

June 9, 2016

Enanta Pharmaceuticals patents FXR agonists

June 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...